Home / Pharmaceuticals / ADME (Absorption, Distribution, Metabolism And Elimination) Toxicology Testing Market By Product ( Instruments, Software Solutions, Assay Systems, Reagents & Others), Technology (In-vitro Tests, In-vivo Tests) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

ADME (Absorption, Distribution, Metabolism And Elimination) Toxicology Testing Market By Product ( Instruments, Software Solutions, Assay Systems, Reagents & Others), Technology (In-vitro Tests, In-vivo Tests) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Published: May 2016 | Report Code: 57834-05-16

This report on ADME toxicology testing market studies various product and technology types. ADME is the abbreviation for absorption, distribution, metabolism and elimination, a pharmacology and pharmacokinetics term that describes the disposition of a drug or compound inside the human body. ADME comprises set of four processes that develop the performance of a drug on human tissue and ADME toxicology testing is applied for the development of a new drug. The key factors assisting the growth of instruments and assay systems market are enhanced accuracy and predictability of ADME –Tox technology, market shift towards in-vitro assays for toxicological studies and increasing global adoption of novel ADME toxicology testing instruments and assay systems.

For the purpose of this study, the global ADME toxicology testing market on the basis of product type is segmented into instruments, software solutions, assays systems, reagents, and others. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

On the basis of technology type ADME toxicology testing market is segmented as in-vivo, and in-vitro; in-vitro technology is bifurcated as biochemical testing and cell testing. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

The ADME toxicology testing market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2013 to 2022 and their CAGRs for the period 2016 to 2022 are provided in this report.

The major key players profiled in the ADME toxicology testing market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Cellartis AB, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Caliper Life Sciences, Inc., Promega Corporation, Life Technologies Corporation, Cyprotex PLC, Beckman Coulter, Inc., Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., MultiCASE, Inc., Xceleron, Inc., ACEA Biosciences, Inc., Albany Molecular Research, Inc., and CeeTox, Inc.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 ADME Toxicology Testing Market, by Product Type, 2015 (USD Mn)
2.2 ADME Toxicology Testing Market Share, by Technology Type, 2015 & 2022 (Value %)
2.3 ADME Toxicology Testing Market Share, by Geography, 2015 (Value %)

Chapter 3 Global ADME Toxicology Testing Market: Market Dynamics and Outlook
3.1 ADME Toxicology Testing : Current and Future Trends
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.6 Market Share Analysis: Key ADME Toxicology Testing Manufacturers, 2015 (%)

Chapter 4 Global ADME Toxicology Testing Market, by Product Type
4.1 Preface
4.2 Instruments
4.3 Software Solutions
4.4 Assays systems
4.5 Reagents
4.6 Others

Chapter 5 Global ADME Toxicology Testing Market, by Technology Type
5.1 Preface
5.2 In-vitro Tests
5.2.1 Biochemical Testing
5.2.2 Cell Testing
5.3 In-vivo Tests

Chapter 6 Global ADME Toxicology Testing Market, by Geography
6.1 Preface
6.2 North America
6.2.1 U.S
6.2.2 Canada
6.3 Europe
6.3.1 U.K
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 China
6.4.2 Japan
6.4.3 Rest of Asia Pacific
6.5 Latin America (LATAM)
6.5.1 Brazil
6.5.2 Mexico
6.5.3 Rest of LATAM
6.6 Middle East and Africa (MEA)

Chapter 7 Future Growth Advocacies

Chapter 8 Company Profiles
8.1 Cellartis AB
8.1.1 Business Description
8.1.2 Financial Health and budget allocation
8.1.3 Product Positions/Portfolio
8.1.4 Key Competitors
8.1.5 News Coverage
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 Key Competitors
8.2.5 News Coverage
8.3 Agilent Technologies, Inc.
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 Key Competitors
8.3.5 News Coverage
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Business Description
8.4.2 Financial Health and budget allocation
8.4.3 Product Positions/
8.4.4 Key Competitors
8.4.5 News Coverage
8.5 Caliper Life Sciences, Inc.
8.5.1 Business Description
8.5.2 Financial Health and budget allocation
8.5.3 Product Positions/Portfolio
8.5.4 Key Competitors
8.5.5 News Coverage
8.6 Promega Corporation
8.6.1 Business Description
8.6.2 Financial Health and budget allocation
8.6.3 Product Positions/Portfolio
8.6.4 Key Competitors
8.6.5 News Coverage
8.7 Beckman Coulter, Inc.
8.7.1 Business Description
8.7.2 Financial Health and budget allocation
8.7.3 Product Positions/Portfolio
8.7.4 Key Compsetitors
8.7.5 News Coverage
8.8 Optivia Biotechnology, Inc.
8.8.1 Business Description
8.8.2 Financial Health and budget allocation
8.8.3 Product Positions/Portfolio
8.8.4 Key Competitors
8.8.5 News Coverage
8.9 Cyprotex PLC
8.9.1 Business Description
8.9.2 Financial Health and budget allocation
8.9.3 Product Positions/Portfolio
8.9.4 Key Competitors
8.9.5 News Coverage
8.10 Molecular Discovery Ltd.
8.10.1 Business Description
8.10.2 Financial Health and budget allocation
8.10.3 Product Positions/Portfolio
8.10.4 Key Competitors
8.4.5 News Coverage

List of Figures

FIG. 1 ADME Toxicology Testing : Market Segmentation
FIG. 2 ADME Toxicology Testing Market, by Product Type, 2015 (USD Mn)
FIG. 3 ADME Toxicology Testing Market Share, by Technology Type, 2015 & 2022 (Value %)
FIG. 4 ADME Toxicology Testing Market Share, by Geography, 2015 (Value %)
FIG. 5 Attractive Investment Proposition, ADME Toxicology Testing Market, 2015
FIG. 6 Key Players Market Share Analysis for ADME Toxicology Testing, 2015 (%)
FIG. 7 Global Instruments Market Revenue, 2013 – 2022 (USD Mn)
FIG. 8 Global Software Solutions Market Revenue, 2013 – 2022 (USD Mn)
FIG. 9 Global Assays Systems Market Revenue, 2013 – 2022 (USD Mn)
FIG. 10 Global Reagents Market Revenue, 2013 – 2022 (USD Mn)
FIG. 11 Global Others Market Revenue, 2013 – 2022 (USD Mn)
FIG. 12 Global In-vitro Tests Market Revenue, 2013 – 2022 (USD Mn)
FIG. 13 Global In-vivo Tests Market Revenue, 2013 – 2022 (USD Mn)
FIG. 14 U.S. ADME Toxicology Testing Market Revenue, 2013 – 2022 (USD Mn)
FIG. 15 Canada ADME Toxicology Testing Market Revenue, 2013 – 2022 (USD Mn)
FIG. 16 U.K. ADME Toxicology Testing Market Revenue, 2013 – 2022 (USD Mn)
FIG. 17 Germany ADME Toxicology Testing Market Revenue, 2013 – 2022 (USD Mn)
FIG. 18 Rest of Europe ADME Toxicology Testing Market Revenue, 2013 – 2022
(USD Mn)
FIG. 19 China ADME Toxicology Testing Market Revenue, 2013 – 2022 (USD Mn)
FIG. 20 Japan ADME Toxicology Testing Market Revenue, 2013 – 2022 (USD Mn)
FIG. 21 Rest of Asia-Pacific ADME Toxicology Testing Market Revenue, 2013 – 2022 (USD
Mn)
FIG. 22 Brazil ADME Toxicology Testing Market Revenue, 2013 – 2022 (USD Mn)
FIG. 23 Mexico ADME Toxicology Testing Market Revenue, 2013 – 2022 (USD Mn)
FIG. 24 Rest of LATAM ADME Toxicology Testing Market Revenue, 2013 – 2022 (USD Mn)

List of Tables

TABLE 1 Global ADME Toxicology Testing Market Revenue, by Product Type, 2013 – 2022 (USD Mn)
TABLE 2 Global ADME Toxicology Testing Market Revenue, by Technology Type, 2013 – 2022 (USD Mn)
TABLE 3 Global ADME Toxicology Testing Market Revenue, by Geography, 2013 – 2022 (USD Mn)
TABLE 4 North America ADME Toxicology Testing Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 5 Europe ADME Toxicology Testing Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 6 Asia - Pacific ADME Toxicology Testing Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 7 Latin America ADME Toxicology Testing Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 8 Middle East and Africa ADME Toxicology Testing Market Revenue, by Region, 2013 – 2022 (USD Mn)

Based on the type of product, the global ADME toxicology testing market is segmented as follows:

  • Instruments
  • Software solutions
  • Assays systems
  • Reagents
  • Others

ADME Toxicology Testing  Market

In year 2015, instruments and assay systems accounted for the largest market share in the global ADME toxicology testing market. The key factors assisting the growth of instruments and assay systems market are enhanced accuracy and predictability of ADME –Tox technology, market shift towards in-vitro assays for toxicological studies and increasing global adoption of novel ADME toxicology testing instruments and assay systems. Issues with toxicity remain one of the key reasons why promising drug candidates fail to make it beyond the preclinical and clinical trials at a cost to both the company and ultimately the patient. Market experts suggest that, introduction of toxicology testing earlier in the drug development process appeared to be a large investment when the new drug development costs surpassed USD 1 billion. Thus, this event was one of the key factors responsible for significant growth in ADME toxicology testing market. In addition, the increasing number of drug targets and volume of assay points in drug discovery process are necessitating the need for identifying and eliminating potential hits with high ADME and toxicity profiles.

Based on the type of technology, the ADME toxicology testing market is segmented into:

  • In-vitro Tests
    • Biochemical Testing
    • Cell Testing
  • In-vivo Tests

In base year 2015, the in-vivo tests accounted the largest share in the market in terms of revenue (USD) due to its efficiency in terms of cost and time over other toxicity testing techniques. With benefits such as increase throughput screening, the ADME toxicology prediction technology is expected to increase in the near future. In-vitro technologies are anticipated to project lucrative growth owing to increasing ethical concerns over animal use in clinical trials. Application of ADME toxicity computer modeling is expected to rise because of associated benefits related to increase throughput screening. The key factors driving ADME toxicology testing market are enhanced accuracy and predictability of ADME-Tox technology, rising ethical concerns over the use of animals in clinical trials, growing prominence of cell-based assays in drug discovery and ADME analysis, and rising demand and awareness for cardiotoxicity and cell imaging.

ADME Toxicology Testing  Market

For the purpose of this study, the global ADME toxicology testing market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

ADME Toxicology Testing Market

In base year 2015, North America accounted for the largest share in the global ADME toxicology testing market, followed by Asia-Pacific, Europe, LATAM and MEA. The key factors assisting the market growth in this region are the supportive government regulations towards new drug development. According to market experts, reduced number of drug failures due to the adoption of ADME toxicology testing is boosting the demand from pharmaceutical and biotechnology companies. Technological advancements such as the application of in-silico techniques that make use of computer-based testing methods to get fast results are expected to drive the ADME toxicology testing market in the future.The Asia-Pacific region (comprising Japan, China and India as major countries) is anticipated to grow at the fastest CAGR during the forecast period 2016 - 2022. The key factors such as ongoing shift of research work to low cost countries, increased government support, and rising collaborations between foreign pharmaceutical companies and local research laboratories.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients